News
Article
This Year in Medicine 2024: Stories that Defined Healthcare
Author(s):
An overview and landing page for future installments from HCPLive's 8th annual This Year in Medicine Series.
As we turn the page on 2024, healthcare systems, professionals, and patients, in many ways, find themselves at a crossroads as they prepare to enter 2025.
2024 was a record year in medicine. With a slew of historic approvals in a multitude of disease states, many specialties find themselves amidst a renaissance of care.
However, even with all this advancement, for many, this year was more of the same—earmarked by struggles to overcome the impact of decades-long barriers to care to provide equitable access and care for underserved communities.
Throughout December, This Year in Medicine, the 8th edition of our annual series reflecting on the groundbreaking stories, persistent challenges, and transformative innovations in healthcare, will feature in-depth articles and multimedia content, spotlighting the most impactful developments within our areas of focus.
As always, this year’s series is a collaboration across the HCPLive Network:
From new therapeutic advances in MASH/MASLD, heart failure, and menopause to the profound early impact of artificial intelligence in neurology, from regulatory milestones like needle-free treatments and home OCT to the evolving understanding of antimicrobial resistance and long COVID, this year’s stories reflect the diversity and dynamism of medicine in 2024.
Stay connected with This Year in Medicine on Facebook, Twitter, and LinkedIn using the hashtag #ThisYearInMedicine, or follow the series on HCPLive’s homepage and daily newsletter. Thank you for joining us in this exploration of healthcare’s continued evolution.
In the future, you will be able to find a list and summaries for each piece of content featured in our This Year in Medicine series. Remember to check back throughout December for new installments and insights!
--------------------
Installments:
Endoscopy in the Age of GLP-1 RAs: 2024 Sees New Risk-Based Perioperative Guidance
To withhold or not to withhold? That was the question for many in 2024 as the community processed how to digest and implement new information on withholding GLP-1 RAs ahead of endoscopic procedures during 2024.
System Integration: How AI Is Weaving Itself into Neurology
Artificial intelligence has quickly found a home in medicine, but what does it mean for neurology specifically? Find out in this article, with perspective across more than half a dozen disease states in neurology.
A Pillared Approach: A Suite of Therapies for a Spectrum of Disease
In recent years, a collection of therapeutic classes and agents have redefined the management of metabolic disease. In 2024, these therapies entered a new realm—heart failure with preserved ejection fraction.
The Long COVID Patient Journey: A Complex and Uncertain Road
More than 4 years removed from the peak of the COVID-19 pandemic in 2020, health systems are now grappling with challenges posed by long-term sequelae of the disease.
Bringing It All Back Home: Reshaping Ophthalmology's Clinic with Home OCT
The FDA-approved Scanly, a home-based OCT device, revolutionizes nAMD care by empowering patients with self-monitoring and enhancing personalized treatment.
Where is the Mental Health Crisis Heading in 2025? Hear from Experts
America's mental health crisis continues to escalate—what drives it, and what lies ahead in 2025? Hear insight from psychiatry and psychology experts.
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor
In a special edition of HCPLive's flagship diabetes podcast, hosts reflect on the advancement in CGM that reshaped care for diabetes and overall health during 2024, which marked the 25th anniversary of the first FDA approval for a CGM system.
2024’s Needle-Free Approvals Transform Management of Anaphylaxis, Influenza in Children
Needle-free treatments, such as neffy and FluMist, offer promising alternatives for children and adults with needle phobia, ensuring access to critical care.
The Slow-Moving Antimicrobial Resistance Train is Picking-up Morbidity and Mortality Steam
Resistance is expected to worsen significantly, but can a combination of both ground-level clinician stewardship actions as well as systemic reforms such as the Pasteur Act at least slow down the train?
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
A trio of subject matter experts reflect on some of the year’s most important developments in the food allergy space, namely the approvals of omalizumab and neffy.
How Digital Health Tools, AI, and Wearables are Transforming Care and Self-Management
Adoption of telemedicine, wearables, and health apps surged during COVID-19. These technologies have become a permanent fixture in healthcare, offering convenience and reducing exposure risks.
Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision
With new revisions of the MS diagnostic criteria being made, clinicians highlighted key updates and the broader implications it has for diagnosis, treatment, and healthcare practices worldwide.
The Rise, Fall (and Future?) of MDMA-Assisted Therapy
MDMA-assisted therapy, a source of hope for many, went on a tumultuous journey in 2024, going from historic hype to setbacks.
Crisis Point: Benzene Concerns in Acne Care
In this episode of Crisis Point, David Light, Neal Bhatia, MD, and Christopher Bunick, MD, PhD, discuss this year's news regarding benzene found in acne products.
